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Abstract: N-glycosylation has remained mostly unexplored in Piroplasmida, an order of tick-
transmitted pathogens of veterinary and medical relevance. Analysis of 11 piroplasmid genomes
revealed three distinct scenarios regarding N-glycosylation: Babesia sensu stricto (s.s.) species add
one or two N-acetylglucosamine (NAcGlc) molecules to proteins; Theileria equi and Cytauxzoon felis
add (NAcGlc)2-mannose, while B. microti and Theileria s.s. synthesize dolichol-P-P-NAcGlc and
dolichol-P-P-(NAcGlc)2 without subsequent transfer to proteins. All piroplasmids possess the gene
complement needed for the synthesis of the N-glycosylation substrates, dolichol-P and sugar nu-
cleotides. The oligosaccharyl transferase of Babesia species, T. equi and C. felis, is predicted to be
composed of only two subunits, STT3 and Ost1. Occurrence of short N-glycans in B. bovis merozoites
was experimentally demonstrated by fluorescence microscopy using a NAcGlc-specific lectin. In vitro
growth of B. bovis was significantly impaired by tunicamycin, an inhibitor of N-glycosylation, indi-
cating a relevant role for N-glycosylation in this pathogen. Finally, genes coding for N-glycosylation
enzymes and substrate biosynthesis are transcribed in B. bovis blood and tick stages, suggesting that
this pathway is biologically relevant throughout the parasite life cycle. Elucidation of the role/s ex-
erted by N-glycans will increase our understanding of these successful parasites, for which improved
control measures are needed.
Keywords: piroplasmids; Babesia; Theileria; Cytauxzoon; N-glycan; dolichol; sugar nucleotides
1. Introduction
Apicomplexan protozoa are obligatory parasites, many of which seriously affect
human and animal health. They undergo complex life cycles that frequently include host
switches and morphological changes. Post-translational modifications (PTMs) of proteins
are intricately involved in numerous aspects of their biology, including invasion of host
cells, egress, differentiation, and protein localization, as well as modification of the host cell
environment to create beneficial conditions for the parasites to complete their life cycle [1].
Among apicomplexan PTMs, there is scarce knowledge about N-glycosylation, one
of the main eukaryotic modifications of proteins. N-glycosylation consists of the addition
of an oligosaccharide of diverse composition and complexity to a surface-exposed Asn
residue of a protein generally destined to the secretory pathway. Certain requisites are
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needed for this pathway, including: (i) A dolichol-P (dol-P) precursor on which the glycan
is first assembled; (ii) an array of Alg (Asn-linked glycosylation) enzymes that take care of
the sequential addition of monosaccharides to this dol-P precursor; (iii) the synthesis of
nucleotide-activated sugars as substrates in the initial steps of N-glycosylation, and, but
not essentially, lipid-bound sugars for the subsequent steps; (iv) a flippase in charge of
transferring the lipid linked oligosaccharide (LLO) and in most cases, lipid-bound sugars
as well, from the cytoplasmic to the luminal side of the rough endoplasmic reticulum
(RER); (v) an oligosaccharide transferase that allocates the formed glycan on a nascent
protein, and (vi) a surface-exposed Asn-X-Ser/Thr sequon in a nascent protein onto which
the glycan is transferred, where X can be any residue but Pro. Independently of the
final N-glycan structure, the first monosaccharides added to the sugar chain are always
two N-acetylglucosamine (NAcGlc) residues, which are followed in most organisms by a
two branch-structure of mannose (Man), glucose and sometimes other monosaccharide
molecules. Only in higher eukaryotes, after N-glycan synthesis and transfer to a protein in
the RER, remodeling of the N-glycan continues at the Golgi apparatus [2].
There is high diversity in N-glycan complexity among different organisms, which is
determined by the repertoire of N-glycosylation enzymes encoded in their genomes [3].
Even among apicomplexans, N-glycans can vary from a basic N-acetyl chitobiose, i.e.,
(NAcGlc)2 in Plasmodium falciparum, to a more complex structure in which (NAcGlc)2 is
linked to a bifurcated branch of 5 Man and 3 glucose residues in Toxoplasma gondii [3,4].
Diverse functions have been described for protein N-glycans in different organisms,
some of which can be hypothesized to be relevant for apicomplexan parasites as well,
such as protein folding, N-glycan-dependent ER-associated degradation of misfolded
proteins (N-glycan ERAD), protection against protease cleavage, cell-cell interactions, and
modulation of and protection from host immune responses [5]. Additionally, apicomplexan-
specific functions, such as participation in gliding motility and in life stage differentiation
have been proposed based on N-glycosylation inhibition experiments in T. gondii and
P. falciparum, respectively [4,6].
N-glycosylation has remained poorly explored in piroplasmids, a vast group of tick-
transmitted apicomplexan hemoprotozoans that include Babesia, Theileria and Cytauxzoon
species, with relevance for veterinary and human health [7,8]. In this study, we analyze
the repertoire of N-glycosylation-related genes in several piroplasmid species, unraveling
interesting and previously undescribed differential features. We also present the first
experimental evidence of the occurrence of a very basic form of N-glycan in B. bovis, one of
the causative agents of bovine babesiosis, and explore its importance for parasite survival.
2. Results and Discussion
2.1. Three N-Glycosylation Scenarios Are Inferred from the Genomic Analysis of Diverse
Piroplasmid Lineages
The repertoire of enzymes involved in N-glycosylation was identified in the predicted
proteomes of 11 piroplasmid species for which genome sequences are available. The first
step in this pathway consists of the assembly of a NAcGlc-P moiety, donated by the sugar
nucleotide UDP-NAcGlc, on a membrane-inserted dol-P, to form dol-P-P-NAcGlc. This
process takes place in the cytoplasmic side of the RER membrane, and is catalyzed by
UDP-NAcGlc:dol-P N-acetylglucosamine phosphotransferase (Alg7, Figure 1). All of the
analyzed piroplasmids were found to contain Alg7 in their proteomes, which implies that
all are able to synthesize a lipid-linked NAcGlc at the RER membrane (Table 1).




Figure 1. N-glycosylation pathways and end products in piroplasmids. (A) Predicted pathway for 
the N-glycosylation of an exported protein in Theileria equi and Cytauxzoon felis: (1) Synthesis of dol-
P-NAcGlc by Alg7; (2) synthesis of dol-P-P-(NAcGlc)2 by Alg13/Alg14 (both processes occur at the 
cytoplasmic leaflet of the rough endoplasmic reticulum (RER) membrane and utilize UDP-NAcGlc 
as sugar donor); (3) synthesis of dol-P-P-(NAcGlc)2-Man by Alg1; (4) flipping to the luminal leaflet 
of the RER by a flippase; (5) transfer of (NAcGlc)2 to a signal peptide-bearing nascent protein by 
oligosaccharyl transferase activity (OST); (6) cleavage of signal peptide liberating the recently syn-
thesized N-glycosylated protein (green); (7) dephosphorylation of dol-P-P to dol-P; (8) flipping of 
dol-P to the cytoplasmic leaflet of the RER for reuse. Babesia s.s. lack step 3, while Theileria s.s. and 
B. microti lack steps 3 and 5. SP: Signal peptide. (B) End products resulting from three different N-
glycosylation enzyme sets: dol-P-P-(NAcGlc)2, and (NAcGlc)2 or Man-(NAcGlc)2 modifying a pro-
tein. (C) graphical references. 
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of an exported protein in Theileria equi and Cytauxzoon felis: (1) Synthesis of dol-P-NAcGlc by Alg7; (2) synthesis of
dol-P-P-(NAcGlc)2 by Alg13/Alg14 (both processes occur at the cytoplasmic leaflet of the rough endoplasmic reticulum
(RER) membrane and utilize UDP-NAcGlc as sugar donor); (3) synthesis of dol-P-P-(NAcGlc)2-Man by Alg1; (4) flipping
to the luminal leaflet of the RER by a flippase; (5) transfer of (NAcGlc)2 to a signal peptide-bearing nascent protein by
oligosaccharyl transferase activity (OST); (6) cleavage of signal peptide liberating the recently synthesized N-glycosylated
protein (green); (7) dephosphorylation of dol-P-P to dol-P; (8) flipping of dol-P to the cytoplasmic leaflet of the RER for reuse.
Babesia s.s. lack step 3, while Theileria s.s. and B. microti lack steps 3 and 5. SP: Signal peptide. (B) End products resulting
from three different N-glycosylatio enzyme sets: dol-P-P-(NAcGlc)2, and (NAcGlc)2 or Man-(NAcGlc)2 modifying a
protein. (C) graphical refer ces.
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1st NAcGlc 2nd NAcGlc Man
Enzyme
Species Alg7 Alg13 Alg14 Alg1 STT3 OST1
i
Clade IV T. equi XP_004830167 XP_004829088 XP_004830080 XP_004832122 XP_004832354 XP_004831427
Clade IIIa C. felis CF000673 CF001791 CF002639 CF004094 CF001242 CF000008
ii Clade VIBabesia s.s.
B. bovis XP_001609261 XP_001610083 XP_001610338 - XP_001609551 XP_001611482
B. bigemina XP_012769992 XP_012766341 - - XP_012768251 XP_012769449
B. divergens Bdiv_013430c Bdiv_003540c Bdiv_029110 - Bdiv_030100 Bdiv_036510
Babesia sp.
Xinjang XP_028870826 XP_028872191 - - XP_028869940 -
B. ovata - BOVATA_021750 - BOVATA_014210 BOVATA_008000
iii
Clade I B. microti XP_021337988 - - - - -
Clade V
Theileria s.s.
T. annulata XP_954592 - - - - -
T. parva XP_765645 XP_765081 KAF5153350.1 - - -
T. orientalis XP_009688943 XP_009690544 XP_009689017 - - -
The second step of N-glycosylation is the addition of another NAcGlc molecule to dol-
P-P-NAcGlc, also using UDP-NAcGlc as donor. This process is catalyzed by a heterodimeric
Alg13/Alg14 enzyme. Canonical versions of Alg13 and Alg14 could be predicted in nine
and six of the analyzed piroplasmid genomes, respectively (Table 1).
Different N-glycosylation pathways result in three possible alternative scenarios
exhibited by three different groups of piroplasmid lineages. B. microti and Theileria sensu
stricto (s.s.) species (T. annulata, T. parva, T. orientalis) lack the genes coding for Alg1
and/or for oligosaccharide transferase (STT3). In other organisms, these two enzymes
are responsible for adding additional Man residues and transferring the N-glycan onto
a nascent protein, respectively. Thus, the end products in species belonging to Theileria
s.s. are the LLO dol-P-P-(NAcGlc)2 and/or dol-P-P-NAcGlc. Importantly, transcriptomic
data available for T. parva shows that Alg7 and Alg13 genes are transcribed in the schizont
stage (data not shown), suggesting that these short LLO fulfill a functional role in these
and other piroplasmids.
A gene encoding for an Alg1 enzyme is present exclusively in the T. equi and C. felis
genomes (Table 1). This enzyme adds a Man moiety to the N-glycan, at the cytoplasmic
side of the RER, using GDP-mannose as donor, to form dol-P-P-(NAcGlc)2Man. The
shared ability of C. felis and T. equi to synthesize this compound correlates with their close
phylogenetic relationship [8,9].
Most eukaryotic organisms add two branches with one and three Man residues to
the pre-existing Man residue by means of the Alg2 and Alg11 glycosyl transferases, using
GDP-Man as sugar donor [2]. However, piroplasmids lack this type of glycosyl transferases,
thus, dol-P-P-NAcGlc, dol-P-P-(NAcGlc)2 and dol-P-P-(NAcGlc)2Man, the latter only in
the case of T. equi and C. felis, are the only LLO produced at the cytoplasmic leaflet of the
RER membrane. LLO need to be flipped across the RER membrane to the luminal side, a
process shown to be protein-dependent and ATP-independent [10]. However, the flippase
enzyme involved in this process remains unidentified for any organism at the molecular
level.
In most eukaryotes, including several apicomplexans, glycosyl transferases further en-
large the N-glycan structure with Man and glucose moieties using dol-bound monosaccha-
rides as donors that are present at the luminal side of the RER membrane [11]. Piroplasmids,
as well as Plasmodium spp. and Giardia lamblia, lack this type of dol-P-sugar-dependent
glycosyl transferases and consequently, any further modifications of their LLO (Table 1) [3].
In a final step, the oligosaccharide is transferred en bloc from the dolichyl pyrophos-
phate to the amide group of a selected Asn residue of a nascent protein (Figure 1). This
process is catalyzed by a heterooligomeric complex of membrane proteins with oligosac-
charyl transferase activity (OST). The OST complex is formed by eight subunits in yeast, six
in Cryptosporidium parvum, four in P. falciparum and only one, the catalytic STT3 subunit, in
G. lamblia and kinetoplastids [12]. In this study, we searched for the piroplasmid orthologs
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of the eight yeast OST subunits and found that Babesia s.s., T. equi and C. felis encode
two of them, STT3 and Ost1, the latter also known as ribophorin 1 (Table 1). Notably, an
OST complex formed exclusively by STT3 and Ost1 has not yet been described for any
other organism so far. In contrast, B. microti and Theileria s.s. species, do neither encode
STT3 nor Ost1 (Table 1). As exemplarily analyzed, the topology of STT3 of B. bovis fol-
lows that of other eukaryotic STT3, comprising a cytosolic N-terminal stretch followed by
13 transmembrane domains and, finally, a hydrophilic domain exposed to the RER lumen
(Figure S1) [12].
Noteworthy, future studies of genome curation and gene re-annotation might help in
the identification of genes that could not be found in this study, such as Alg13 and Alg14
of some piroplasmids. Indeed, the identification of T. parva Alg14, as well as indications for
the presence of an Alg14 orthologue in the genome of T. annulata, were recently reported
after re-examination of the genomes of these two Theileria spp. [13].
A great variety of LLO can act as donors for OST in different organisms. Importantly,
it has been experimentally shown that dol-P-P-NAcGlc fulfills the minimum requirements
to act as a glycosyl donor for OST, while the efficiency of transfer is significantly improved
by addition of a second NAcGlc moiety, as in dol-P-P-(NAcGlc)2 [14].
Summarizing, our findings highlights three principal scenarios of N-glycan formation
in piroplasmids: (i) N-glycosylation of proteins with (NAcGlc)2 or NAcGlc (Babesia s.s.);
(ii) N-glycosylation of proteins with (NAcGlc)2Man (T. equi and C. felis); and (iii) synthesis
of the LLO dol-P-P-NAcGlc and dol-P-P-(NAcGlc)2 that are not transferred to proteins
(B. microti and Theileria s.s.). It can be observed that these three N-glycosylation enzyme sets
can be assigned to the piroplasmid lineage of Babesia s.s. (Clade VI, set i), the closely related
lineages of T. equi and C. felis (Clades IV and IIIa, respectively, set ii) and the distantly
related B. microti and Theileria s.s. (Clades I and V, set iii) [8,9]. Similar to what was
recently reported for piroplasmid C1A cysteine proteases and rhomboid proteinases, this
observation corroborates the currently recognized phylogeny of piroplasmids [15,16]. On
the other hand, the differences observed in the N-glycosylation pathway between B. microti
and Babesia s.s., and between T. equi and Theileria s.s., underscore the need to revise the
taxonomic placement of these two piroplasmids within the Babesia and the Theileria genera,
respectively, as has been put forward before [8,9,17].
Notably, it has been shown that Theileria s.s. and Babesia s.s. merozoite blood stages
invade host cells by entirely different mechanisms. The invasion of Theileria s.s. sporozoites
is driven by the formation of a zipper between the parasite and the host cell membranes,
and, subsequently, the parasite resides naked in the host cell cytoplasm [18]. In contrast,
Babesia s.s. invade their host cells by formation of a tight moving junction, resulting in
the formation of a parasitophorous vacuole which encases the parasite within the host
cell cytoplasm, and then dissolves [19]. It remains to be investigated whether there is a
relationship between the end products of the respective N-glycosylation pathways of these
two piroplasmid lineages and the distinct mechanisms of host cell invasion.
The reduced repertoire of N-glycosylation enzymes found in piroplasmids as com-
pared to higher eukaryotes could have resulted from secondary loss. This notion is in
line with the hypothesis that all extant eukaryotes derive from a relatively complex com-
mon eukaryotic ancestor that lost some features along evolution due to adaptations to
parasitism, among other events [20]. Moreover, it has been suggested that some kind of
N-glycosylation was present in LUCA since both eubacteria and archaea also assemble
oligosaccharides—though of different nature from their eukaryotic counterparts—onto
a lipid precursor at their cellular membranes [21]. Consistently, we have observed that
piroplasmid Alg7, Alg13, Alg14, and Alg1 are homologs of bacterial glycosyltransferases,
similar to what has been reported for yeast Alg13 and Alg14 (results not shown) [22].
2.2. Piroplasmid Genomes Encode All Necessary Enzymes to Synthesize N-Glycan Substrates
Sugar nucleotides and dol-P are the only substrates used in the N-glycosylation
pathway of piroplasmids. Regarding the first, UDP-NAcGlc is the donor for Alg7 and
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Alg13/Alg14, while GDP-Man is used as sugar donor for Alg1, which, as mentioned before,
is present in T. equi and C. felis. The biosynthetic pathway of these nucleotide sugars
was inferred in P. falciparum from the enzyme-coding genes identified in its genome and
experiments using radiolabeled sugars [23]. The precursor of UDP-NAcGlc synthesis is
glucose-6P, that undergoes conventional eukaryotic de novo routes, in which one of the
intermediaries is glucosamine-6P (Glc-6P). Additionally, a salvage pathway involves the
incorporation of glucose, fructose or Glc from the medium and their conversion to Glc-6P
by hexokinase (HK). Glc-6P undergoes N-acetylation, forming NAcGlc-6P which is in turn
transformed to GlcNAc-1P. Finally, UDP-N-acetylglucosamine pyrophosphorylase takes
care of the formation of the nucleotide sugar with involvement of UTP. GDP-Man synthesis,
on the other hand, starts with the conversion of fructose-6-P into Man-6-P, or can also
follow a salvage route, with the uptake of Man from the medium and its transformation
to Man-6P by HK. Man-6P is then converted to Man-1-P which, by association with a
GTP molecule, catalyzed by Man-1-phosphate guanyltransferase, yields GDP-Man and
pyrophosphate (Figure S2).
Noteworthy, reverse BLAST showed that orthologues of P. falciparum genes implicated
in the biosynthetic pathways of UDP-NAcGlc and GDP-Man are present in all piroplasmid
genomes studied in this work. The corresponding enzymes of B. bovis, T. equi and T. parva,
which represent the three different N-glycosylation scenarios revealed in this study, are
listed in Table S1. It is important to note that all piroplasmids use GDP-Man as sugar
donor for dol-P sugars in the biosynthesis of glycosylphosphatidylinositol (GPI), while
exclusively T. equi and C. felis use this sugar nucleotide also for N-glycosylation [24].
Dol, a cis-polyisoprenoid, in which the terminal isoprene unit is saturated and oxi-
dized to an alcohol, is a substrate in both the N-glycosylation and the GPI biosynthetic
pathways. In apicomplexan parasites, as well as in eubacteria and plant chloroplasts,
isoprenoid precursors are synthesized through the methylerythritol phosphate (MEP) path-
way, while in other eukaryotes, synthesis takes place through the mevalonate pathway.
The MEP pathway is a seven-step process that starts with pyruvate and ends with the
synthesis of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), and,
in apicomplexans, takes place in the apicoplast [25]. All MEP pathway enzymes were
shown to be encoded in the genomes of B. bovis, B. microti, and B. orientalis, and expression
of two of them (BoDXS and BoDXR) was experimentally demonstrated in merozoites (mz)
of the latter [26,27]. The MEP pathway is absent in mammals, and inhibitors of this route
hamper the in vitro growth of Babesia spp. mz, making it an attractive therapeutic target
against piroplasmids [26–28].
It has been proposed for P. falciparum that the end products of the MEP pathway,
IPP and DMAPP, are converted outside the apicoplast into farnesyl diphosphate (FPP)
and geranylgeranyl diphosphate (GGPP), and that the final steps of dol-P synthesis take
place at the cytoplasmic leaflet of the RER membrane [25]. Thus, some kind of transport
system needs to carry these hydrophobic molecules through the hydrophilic cytoplasmic
milieu. There, an isoprenoid elongation step, catalyzed by cis-prenyltransferase (CPT)
takes place, resulting in a polyprenyl diphosphate bearing a varying number of isoprene
units which, in P. falciparum, has been determined to be 15 to 19. Dephosphorylation
by polyprenyl diphosphate phosphatase yields polyprenol, which is then reduced by
polyprenol reductase (PPRD) to dol [25]. Dol needs then to undergo phosphorylation to be
utilized in the N-glycosylation and GPI synthesis pathways. In yeast, this step is carried out
by SEC59 dolichol kinase (NP_013726.1). Homology searches using P. falciparum CPT and
PPRD as queries showed that all piroplasmid genomes analyzed encode these enzymes.
Also, SEC59 homologues were found in all piroplasmids (Table S2).
In addition to de novo synthesis, evidences of dol recycling have been obtained in
yeast. After transfer of the glycan to an Asn residue of a nascent protein, dol-P-P was
shown to be dephosphorylated yielding dol-P, which was flipped to the cytoplasmic leaflet
of the RER membrane, becoming thus available for reuse [29]. This dol-P flipping step
likely also takes place in piroplasmids (Figure 1). In addition to its use in N-glycosylation
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and GPI biosynthesis, dol was demonstrated to be covalently added to terminal cysteine
residues of P. falciparum proteins [30]. It remains to be determined whether piroplasmids
also possess this type of PTM.
In short, the genome searches carried out in this study show that all analyzed piroplas-
mids possess the necessary machinery to synthesize N-glycan substrates independently
from their hosts.
2.3. The N-Glycan N-Acetyl-chitobiose Can Be Detected on the B. bovis mz Surface
To experimentally examine if the predicted N-glycosylation pathway is operational in
the bovine piroplasmid B. bovis, smears of infected erythrocytes were incubated with biotin-
conjugated Griffonia simplicifolia Lectin II (GSL II), followed by detection with Fluorescein
Isothiocyanate (FITC)-labeled streptavidin and observation in a fluorescent microscope.
GSLII is a dimeric glycoprotein that specifically binds α- or β-linked NAcGlc residues on
the non-reducing terminal end of oligosaccharides. The labeling of B. bovis mz observed
with this lectin is consistent with the in silico prediction of the occurrence of short N-
glycans, composed of one or two NAcGlc moieties, modifying the surface proteins of this
parasite (Figure 2). Additionally, LLO associated to parasite membranes might become
labeled as well. The fluorescent pattern obtained shows diffuse labeling that corresponds
to the parasite surface and some strong spots consistent with RER membrane labeling.
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i . Detection of short NAcGlc glycans in B. bovis mz. Fixed smears of B. bovis-infected
erythrocytes were incubated with biotin-labeled GSLII lectin, followed by FITC-streptavidin and
4,6-diamidino-2-phenylindole (DAPI) for nuclei Scheme 1000× in an epifluorescence microscope
using filters to detect FITC (a) or DAPI (b). (c) Merged image.
i t B Glycosylated
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,
ore surface-exposed Asn-X-Ser/Thr sequons, where X can be any amino acid
but Pro. Only sites with a high prediction for the presence of a signal peptide and N-
glycosylation were considered, resulting in the identification of 13 membrane-bound and
50 exported proteins (Table S3). Apart from a large number of “hypothetical” proteins,
the list includes proteins shown to participate in host-pathogen interactions, such as 12D3
antigen, thrombospondin-related anonymous protein (TRAP) and spherical body protein
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3 (SBP3), the first two of which also constitute vaccine candidates [31–33]. Notably, SBP3
has been experimentally shown to belong to the exportome, and to be localized in the
erythrocyte cytosol [34]. Additionally, several smORFs that belong to a large family of
variable proteins of still unknown function are also likely to be N-glycosylated [35]. Most
of the identified proteins carried a single highly predicted N-glycosylation site, whereas
the presence of 2 or up to 7 sites was less frequent (Figure S3).
Importantly, however, in silico prediction of N-glycosylation does not necessarily
correspond to the situation encountered in vivo. It has been shown for other organisms
that up to 35% of proteins bearing an N-glycosylation site might not be glycosylated at the
RER [36,37]. Actual addition of an N-glycan depends on the position of the sequon, being
less frequent on those close to a transmembrane domain, the C-terminus or a disulfide
bridge [12]. In Trypanosoma brucei, it was shown that the presence of certain amino acids in
the proximity of a sequon critically influences the N-glycosylated status of a protein [38].
Additionally, N-glycosylation of a particular protein can vary with the life cycle stage, as
shown for P. falciparum [6].
In conclusion, a considerable number of B. bovis proteins bear the necessary features
to be N-glycosylated, but the actual presence of N-glycans in specific proteins and at
particular life stages remains to be experimentally demonstrated. Also, the presence of N-
glycosylation sequons has to be taken into account when producing recombinant proteins
in eukaryotic systems, since abnormal N-glycosylation patterns are likely to occur [36].
2.5. N-Glycosylation Enzyme Genes Are Transcribed in B. bovis Blood and Tick-Kinete
Parasite Stages
We compared the levels of transcription of B. bovis genes involved in N-glycosylation
-related pathways between bovine blood (mz) and tick hemolymph (kinetes) parasite stages.
The normalized data are shown in Figure 3 and Table S4. None of the genes coding for
enzymes involved in the N-glycosylation pathway have a differential pattern of expression
among blood and kinete stages, with the exception of transcripts for the Alg13 gene which
were significantly higher in blood stages. Some of the genes showed marginal, but still
detectable, levels of expression in both (Figure 3A). Similarly, no significant differences
in the levels of transcripts were found for the two genes involved in the synthesis of dol
(Figure 3B).
In contrast, differential transcription levels of genes involved in UDP-NAcGlc synthe-
sis in B. bovis blood and tick-stage parasites seems to indicate the favoring of a different
pathway in each of these stages. While blood stages have a marked increased transcription
of the genes involved in de novo synthesis of UDP-NAcGlc from glucose-6-P, G6PI, and
GFPT, transcription of the gene coding for HK, the hexokinase that participates in the
scavenging of Glc from the milieu by transforming it to Glc-6-P, is substantially increased
in the tick stages. Expression of PAGM, that transforms NAcGlc-6P into NAcGlc-1P before
its coupling to the UDP nucleotide is also significantly increased at the transcriptional level
in tick stages (Figure 3B and Figure S2).
As mentioned before, UDP-NAcGlc is the only sugar nucleotide substrate used for
N-glycan synthesis in B. bovis, while GDP-Man acts as sugar donor exclusively in GPI
biosynthesis. Thus, we explored whether the transcription level differences between blood
and tick stages observed in the UDP-NAcGlc biosynthetic pathway were also observed in
the case of the GDP-Man biosynthetic pathway. Surprisingly, transcription of the genes
encoding MPI, PMM, and MPG that participate in GDP-Man synthesis are all increased
(8, 70, and 2-fold, respectively) in tick—as compared to blood stages, following the same
pattern of HK, which also participates in the scavenging of Man that allows its incorporation
to this route (Figure 3C and Figure S2).
Our results indicate that N-glycosylation of proteins as well as synthesis of N-glycosyl-
ation substrates is operative in both blood and tick stages. They also highlight that synthesis
of the sugar nucleotide precursor for GPI synthesis, GDP-Man, could be of particular
importance for the tick stage. The biological significance of the observed differences in
transcription levels is worth exploring in future research.
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B. bovis stages. (A) N-glycosylation pathway-encoding genes. (B) Genes related to the biosynthesis of
UDP-NAcGlc (S) and dol (D), the substrates for N-glycan synthesis in B. bovis. (C) Genes related to
the synthesis of GDP-Man, which in B. bovis is only used as sugar donor for GPI biosynthesis. Red
bars: Blood stages; blue bars: Tick stages.
2.6. N-Glycosylation Is Important but Not Essential for In Vitro Growth of B. bovis mz
As a first step towards evaluating the biological relevance of piroplasmid N-glycosylat-
ion, the effects of tunicamycin (Tun) on the in vitro growth of B. bovis merozoites was
analyzed. Tun inhibits N-glycosylation in a wide variety of organisms, from archaea to
higher eukaryotes, by blocking the transfer of UDP-GlcNAc to dol-P by specific interaction
with Alg7 [39–41]. B. bovis cultures exposed to growing concentrations of Tun (0 to 30 µM)
for 72 h showed a dose-dependent decrease in percentages of parasitized erythrocytes
(PPE) (Figure 4). These results agree well with those observed for P. falciparum and T. gondii
treated with similar concentrations of this drug [4,6,42]. Despite a significant impairment
of B. bovis growth in the presence of Tun, a considerable number of parasites were still
able to reproduce, suggesting an important but not essential role for N-glycosylation in
erythrocyte invasion and parasite survival, at least in in vitro cultures. It remains to be
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determined whether Tun-treated parasites are able to develop in vivo and produce acute
and persistent infection, develop sexual stages and reproduce sexually in the tick vector,
and whether these parasites have an attenuated phenotype.
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The role/s of N-glycosylation in piroplasmids and other apicomplexans remains to be
elucidated. In higher eukaryotes, N-glycans participate in quality control of protein folding
(N-glycan QC) and N-glycan ERAD. However, the short glycans present in piroplasmids
cannot fulfill these roles, indicating that N-glycan QC and ERAD are not needed for
piroplasmid viability [43].
In T. gondii, Tun-treated parasites showed defective motility, suggesting that N-
glycosylation could be involved in glideosome function, an essential feature to ensure host
cell invasion and survival [4,44]. In P. falciparum, on the other hand, Tun impaired the
differentiation of trophozoites to the schizont stage by still undefined mechanisms [6].
Our observations that transcription of N-glycosylation genes occurs in B. bovis parasite
life stages that live either inside bovine erythrocytes or in the tick hemolymph suggest
that this process could be related to motility, invasion, differentiation, and/or other mech-
anisms needed for parasitic life in these environments. However, this speculation needs
experimental confirmation. Rapidly developing genetic tools could be used in the future to
carry out loss of function experiments in order to locate the process or processes for which
N-glycosylation is critical for piroplasmids [45].
3. Materials and Methods
3.1. Bioinformatic Analysis
Homologous genes to those encoding the enzymes that participate in the N-glycosylati-
on pathway, as well as in sugar nucleotide synthesis and the final steps of dol-P synthesis
of Saccharomyces cerevisiae S288C and/or P. falciparum strain 3D7 [3,23,25,46] were searched
for in the available genomes of B. bovis strain T2Bo [47], B. bigemina strain BOND [48], B.
divergens strain 1802A [49], B. ovata strain Miyake [50], Babesia sp. Xinjang [51], B. microti
strain R1 [52], T. parva strain Muguga [53], T. annulata strain Ankara [54], T. orientalis strain
Shintoku [55], T. equi strain WA [17], and C. felis strain Winnie [56]. The algorithms of
NCBI BLAST (blast.ncbi.nlm.nih.gov/Blast.cgi), KEGG Pathway Database (www.genome.
jp/kegg/pathway.html), and PiroplasmaDB (piroplasmadb.org/piro/) were used. Con-
served domains and transmembrane domains of individual proteins were verified in the
NCBI Conserved domains database (www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi?)
and TOPCONS (http://topcons.net/pred/), respectively. For the analysis of the whole
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predicted proteome of B. bovis, T2Bo strain, TOPCONS (topcons.net/pred/) and DeepLoc
(www.cbs.dtu.dk/services/DeepLoc/) were used to differentiate exported, soluble and
membrane-bound proteins. NetNGlyc 1.0 Server (www.cbs.dtu.dk/services/NetNGlyc/)
was used to predict N-glycosylation sites with a probability of 0.75 or higher. In the case
of transmembrane proteins, only those with surface-exposed N-glycosylation sites were
chosen.
3.2. Parasite Cultures
B. bovis mz of the Argentine S2P pathogenic strain [57] were in vitro cultured on
bovine erythrocytes, in 75 cm2 tissue culture bottles, essentially as described by Levy and
Ristic [58]. The basic culture medium (BCM) consisted in M199 (Sigma-Aldrich, St. Louis,
MO, USA)/5 mM HEPES (Sigma-Aldrich), 100 µg/mL streptomycin, 100 IU/mL penicillin,
pH 7.2. This medium was supplemented with normal bovine serum from the same donor
of erythrocytes in a BCM/serum proportion of 60:40 (v/v) (BCM-S). Cultures were grown on
10% packed bovine erythrocytes/90% BCM-S (v/v), at 37 ◦C, in a 5% CO2 atmosphere, with
daily changes of BCM-S, using a starting PPE of 1%. Growth was evaluated by microscopic
observation of Giemsa-stained smears (1000×). For maintenance, subcultures were started
when PPE reached 3%.
3.3. Detection of N-Glycosylation by Fluorescence Microscopy
Smears of B. bovis S2P-infected erythrocytes were prepared, dried at room temperature
for 30 min, washed once in phosphate-buffered saline (PBS) and fixed with cold acetone
for 1 min. After washing with PBS, smears were blocked with 1% (w/v) bovine serum
albumin in PBS for 30 min, followed by overnight incubation with 2 µg/mL biotinylated
GSL-II (Vector Laboratories, Burlingame, CA, USA) or PBS as a negative control, at 4 ◦C.
After two washes with PBS/0.05% Tween-20 for 10 min, slides were incubated with FITC-
labeled streptavidin conjugate (Invitrogen, Waltham, MA, USA), diluted 1:1000 for 20 min
at room temperature in the dark. B. bovis nuclei were labeled by incubation for 5 min
with 2 µg/mL DAPI, followed by several washes with PBS. Slides were examined by
fluorescence microscopy in a Nikon Eclipse 80i microscope at 1000× magnification.
3.4. Transcriptomics Analysis
The analysis of gene regulation during B. bovis infection of mammalian host and
tick vector was performed by using RNA-Seq data sets deposited in the NCBI Gene
Expression Omnibus (GEO; https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE1
44066) under accession number GSE144066. Briefly, the datasets were generated from
B. bovis blood stages isolated from infected calves and B. bovis kinete stages from female
Ripicephalus microplus tick hemolymph as previously described [59]. Evaluation of up-
regulation of the genes of interest was compared by the log10 CPM of transcripts of the two
B. bovis stages from vertebrate and invertebrate hosts.
3.5. Inhibition Tests
A B. bovis-infected erythrocyte suspension in BCM-S was distributed in 1 mL aliquots
in the 6 central wells of 24-well plates with an initial PPE of approximately 1.5%, while the
external wells were filled with 1 mL sterile distilled water. At T0, all suspensions received
20 µL of M199 medium containing different amounts of Tun prepared from a 1 mM stock in
M199, so that the final Tun concentrations were 0, 0.3, 1, 3, and 10 µM. Each concentration
was tested in triplicate wells. A 700 µL aliquot of supernatant was daily removed from
each well and replaced with an equal amount of BCM-S containing the corresponding
amount of Tun. After 72 h, PPEs were determined in Giemsa-stained smears, counting a
minimum of 3000 erythrocytes/slide. The statistical significance of the PPE differences
between treated and untreated cultures was estimated using the Student’s t-test.
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4. Conclusions
In summary, our work provides new information about the occurrence and biological
relevance of N-glycosylation in B. bovis and predicts the types of N-glycans and/or LLO
present in this and other piroplasmids. Knowledge on the type, extent and biological
relevance of N-glycosylation in these parasitic protozoa can help in the understanding of
their survival strategies and pathogenicity mechanisms and in the design of control tools
to alleviate the significant burden they impose on human and animal health.
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involved in the synthesis of the sugar nucleotides UDP-NAcGlc and GDP-Man in P. falciparum and
the piroplasmids B. bovis, T. equi and T. parva, Table S2: Identification of three enzymes participating
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of B. bovis, Table S4: Transcription levels of N-glycosylation -related genes in B. bovis blood and
tick stages.
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